Related Experiment Video

Updated: Oct 25, 2025

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
09:00

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

8.3K

Gene editing for cardiovascular disease prevention

Mark Nicholls1

  • 1MNmedia, Swaffham, Norfolk, UK.

European Heart Journal
|August 6, 2021
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
08:14

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Published on: October 3, 2019

12.5K
CRISPR-Cas9-Mediated Precise Knock-In Edits in Zebrafish Hearts
06:52

CRISPR-Cas9-Mediated Precise Knock-In Edits in Zebrafish Hearts

Published on: September 13, 2022

3.6K

Related Experiment Videos

Last Updated: Oct 25, 2025

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
09:00

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

8.3K
Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
08:14

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Published on: October 3, 2019

12.5K
CRISPR-Cas9-Mediated Precise Knock-In Edits in Zebrafish Hearts
06:52

CRISPR-Cas9-Mediated Precise Knock-In Edits in Zebrafish Hearts

Published on: September 13, 2022

3.6K

Related Concept Videos

CRISPR01:59

CRISPR

53.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
53.6K
What is Genetic Engineering?00:49

What is Genetic Engineering?

76.3K
Overview
76.3K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

716
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
716
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

15.4K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
15.4K

Articles linked to this work by shared authors, journal, and citation graph.

Detection of SARS-CoV-2 in aerosol and surface samples in high acuity hospital settings during community epidemic waves - implications for risk-based infection control.

Respiratory medicine·2026

Prevalence, features and workplace factors associated with burnout among intensivists in Australia and New Zealand.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine·2023

Measuring the Impact of ICU Strain on Mortality, After-Hours Discharge, Discharge Delay, Interhospital Transfer, and Readmission in Australia With the Activity Index.

Critical care medicine·2023

Increasing ICU capacity to accommodate higher demand during the COVID-19 pandemic.

The Medical journal of Australia·2021

Gut microbe-generated metabolite trimethylamine N-oxide and risk of abdominal aortic aneurysm: a cohort study.

European heart journal·2026

Exercise training for cardiovascular prevention in patients with cancer.

European heart journal·2026

Trientine for hypertrophic cardiomyopathy: a phase 2 trial.

European heart journal·2026

Micro- and nano-plastics in the coronary circulation and air pollution exposure in ischaemic heart disease presentation.

European heart journal·2026

Influenza vaccination, incident atrial fibrillation, and cardiovascular outcomes.

European heart journal·2026

The dark genome in cardiovascular medicine.

European heart journal·2026

Innovative microneedle-integrated hydrogels: a promising strategy for diabetic foot ulcer management.

Frontiers in bioengineering and biotechnology·2026

A Systematic Review of Three-Dimensional Printing in Medical Education: Educational Impact and Methodological Quality.

Journal of medical education and curricular development·2026

Efficacy differences and predictors of personalized mixed acoustic therapy in chronic tinnitus patients with and without hearing loss.

Frontiers in neurology·2026

Immuno-phage synergy driven by fitness costs: turning bacterial phage resistance into therapeutic gain through evolutionary traps.

Frontiers in immunology·2026

Inhibiting the uPAR/FPR1 interactions reduces blood-retinal barrier breakdown and improves retinal function in a rat model of diabetes.

Frontiers in neuroscience·2026

Nanostructured Surface Modifications for Cardiac Implants: From Bench to Bedside.

Current cardiology reviews·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us